Ronghua Dai

977 total citations
53 papers, 797 citations indexed

About

Ronghua Dai is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Ronghua Dai has authored 53 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 18 papers in Complementary and alternative medicine and 14 papers in Pharmacology. Recurrent topics in Ronghua Dai's work include Traditional Chinese Medicine Analysis (16 papers), Natural product bioactivities and synthesis (12 papers) and Hormonal and reproductive studies (6 papers). Ronghua Dai is often cited by papers focused on Traditional Chinese Medicine Analysis (16 papers), Natural product bioactivities and synthesis (12 papers) and Hormonal and reproductive studies (6 papers). Ronghua Dai collaborates with scholars based in China, United States and Germany. Ronghua Dai's co-authors include J. Wayne Streilein, David Y.W. Lee, Wen Ma, Xiaoning Zhao, Yan Peng, Yun Wu, Kai Bi, Ying Shang, Jun Yamada and M. Reza Dana and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Chemical Engineering Journal.

In The Last Decade

Ronghua Dai

51 papers receiving 779 citations

Peers

Ronghua Dai
Diya Lv China
Guoyu Li China
Yi Jin China
Zhi Sun China
Kyoo-Seok Ahn South Korea
Diya Lv China
Ronghua Dai
Citations per year, relative to Ronghua Dai Ronghua Dai (= 1×) peers Diya Lv

Countries citing papers authored by Ronghua Dai

Since Specialization
Citations

This map shows the geographic impact of Ronghua Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronghua Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronghua Dai more than expected).

Fields of papers citing papers by Ronghua Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronghua Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronghua Dai. The network helps show where Ronghua Dai may publish in the future.

Co-authorship network of co-authors of Ronghua Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Ronghua Dai. A scholar is included among the top collaborators of Ronghua Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronghua Dai. Ronghua Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Wei, et al.. (2025). Integrated untargeted and targeted metabolomics to reveal the mechanisms of herbal medicine HLXLD on Alzheimer's disease. Journal of Chromatography B. 1265. 124746–124746.
2.
Wang, Haiwei, et al.. (2025). Dual vacancy defect-enhanced FJU-200/CdS heterojunction for ultrasensitive photoelectrochemical detection of CA19-9: Mechanism and performance study. Chemical Engineering Journal. 505. 159934–159934. 4 indexed citations
3.
Qin, Ying, et al.. (2024). Late-model Bi-MOF&CdS-QDs materials: Excellent properties and performance in PEC sensors for lung cancer markers. Chemical Engineering Journal. 490. 151560–151560. 19 indexed citations
6.
Shang, Ying, et al.. (2021). Flavonoids derived from Anemarrhenae Rhizoma ameliorate inflammation of benign prostatic hyperplasia via modulating COX/LOX pathways. Journal of Ethnopharmacology. 284. 114740–114740. 23 indexed citations
8.
Wang, Siqi, David Yue-Wei Lee, Ying Shang, et al.. (2021). The bioactive alkaloids identified from Cortex Phellodendri ameliorate benign prostatic hyperplasia via LOX-5/COX-2 pathways. Phytomedicine. 93. 153813–153813. 16 indexed citations
9.
Liu, Jing, et al.. (2021). Role of Levo-tetrahydropalmatine and its metabolites for management of chronic pain and opioid use disorders. Phytomedicine. 90. 153594–153594. 20 indexed citations
11.
Zhao, Xiaoning, Siqi Wang, Linlin Xie, et al.. (2019). Characterization and screening of cyclooxygenase-2 inhibitors from Zi-shen pill by affinity ultrafiltration-ultra performance liquid chromatography mass spectrometry. Journal of Ethnopharmacology. 241. 111900–111900. 23 indexed citations
12.
Wang, Nannan, Xiaoning Zhao, Yiran Li, et al.. (2018). Arachidonic acid metabonomics study for understanding therapeutic mechanism of Huo Luo Xiao Ling Dan on rat model of rheumatoid arthritis. Journal of Ethnopharmacology. 217. 205–211. 23 indexed citations
13.
Wang, Nannan, et al.. (2016). Arachidonic acid metabolomic study of BPH in rats and the interventional effects of Zishen pill, a traditional Chinese medicine. Journal of Pharmaceutical and Biomedical Analysis. 128. 149–157. 20 indexed citations
15.
Lee, David Y.W., Gang Deng, Zhongze Ma, et al.. (2015). Synthesis and biological evaluation of 2-alkyl-2-methoxymethyl-salvinorin ethers as selective κ-opioid receptor agonists. Bioorganic & Medicinal Chemistry Letters. 25(20). 4689–4692. 8 indexed citations
17.
Li, Guoyu, Ronghua Dai, Yueping Ma, et al.. (2011). Two new polyacetylenic compounds fromAtractylodes chinensis(DC.) Koidz.. Journal of Asian Natural Products Research. 13(4). 346–349. 13 indexed citations
19.
Dai, Ronghua, et al.. (2002). Determination of Barbaloin in Aloe vera L. var. chinensis (Haw.) Berger and Aloe barbadensis Miller by HPLC. Journal of Chinese Pharmaceutical Sciences. 11(2). 22. 2 indexed citations
20.
Dai, Ronghua, Susan F. Grammer, & J. Wayne Streilein. (1993). Fresh and cultured Langerhans cells display differential capacities to activate hapten-specific T cells. The Journal of Immunology. 150(1). 59–66. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026